
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Intrinsic Value
The intrinsic value of one
ACAD
stock under the Base Case scenario is
19.66
USD.
Compared to the current market price of 21.98 USD,
ACADIA Pharmaceuticals Inc
is
Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ACADIA Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
ACADIA Pharmaceuticals Inc
Balance Sheet Decomposition
ACADIA Pharmaceuticals Inc
Current Assets | 871m |
Receivables | 114m |
Other Current Assets | 757m |
Non-Current Assets | 261m |
PP&E | 54m |
Intangibles | 117m |
Other Non-Current Assets | 90m |
Free Cash Flow Analysis
ACADIA Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
ACADIA Pharmaceuticals Inc
Revenue
|
996m
USD
|
Cost of Revenue
|
-79m
USD
|
Gross Profit
|
917m
USD
|
Operating Expenses
|
-682m
USD
|
Operating Income
|
235m
USD
|
Other Expenses
|
-6m
USD
|
Net Income
|
229m
USD
|
ACAD Profitability Score
Profitability Due Diligence
ACADIA Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Score
ACADIA Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
ACAD Solvency Score
Solvency Due Diligence
ACADIA Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Score
ACADIA Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ACAD
is 27.26 USD
with a low forecast of 15.15 USD and a high forecast of 38.85 USD.
Dividends
Current shareholder yield for ACAD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ACAD
stock under the Base Case scenario is
19.66
USD.
Compared to the current market price of 21.98 USD,
ACADIA Pharmaceuticals Inc
is
Overvalued by 11%.